The prognostic significance of isolated tumor cells in the lymph nodes of gastric cancer patients.
BACKGROUND
The clinical significance of isolated tumor cells (ITC) detected immunohistochemically in the lymph nodes of gastric cancer patients is controversial. The aim of this study was to examine the prognostic impact of ITC in patients with gastric cancer.


METHODS
The data of a total of 402 patients with pathological T2N0 and T2N1 gastric cancer who underwent gastrectomy with D2 lymph node dissection between 1984 and 1990 at four participant hospitals were analyzed. All resected lymph nodes were reexamined by serial sectioning with hematoxylin & eosin (H&E) staining, and evaluated by immunohistochemistry using antibody against cytokeratin (AE1/3). The prevalence and prognostic significance of ITC were investigated.


RESULTS
ITC were detected in 187 of the 402 (47%) patients. A multivariate analysis identified the nodal status, histological type, and tumor size as significant factors predictive of the presence/absence of ITC. The 5-year and 10-year overall survival rates of patients with vs those without ITC were 84.4% (95% confidence interval [CI], 79.1-89.0) and 70.4% (95% CI, 64.1-76.7) vs 83.9% (95% CI, 78.6-89.2) and 72.0% (95% CI, 65.4-78.5), respectively. The hazard ratio for death in patients with ITC as compared with those without ITC was 0.90 (95% CI, 0.64-1.26; P = 0.53).


CONCLUSIONS
The presence of ITC in the lymph nodes does not affect the prognosis of patients with gastric cancer who have undergone gastrectomy with D2 lymph node dissection.
Fukagawa
Takeo
T
Gastric Surgery Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Sasako
Mitsuru
M
Ito
Seiji
S
Nakanishi
Hayao
H
Iinuma
Hisae
H
Natsugoe
Shoji
S
Katai
Hitoshi
H
Shimoda
Tadakazu
T
D014408:Biomarkers, Tumor; D016001:Confidence Intervals; D005260:Female; D005743:Gastrectomy; D006801:Humans; D007150:Immunohistochemistry; D007564:Japan; D007633:Keratins; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging / Q000473:pathology; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011379:Prognosis; D011446:Prospective Studies; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D016019:Survival Analysis; D014463:Ultrasonography
D014408:Biomarkers, Tumor; D007633:Keratins
Cancer. 2002 Jun 1;94(11):2867-73
12115374
Semin Surg Oncol. 2003;21(1):19-22
12923912
Cancer. 2008 Apr 15;112(8):1672-8
18286534
Ann Surg Oncol. 2002 Jan-Feb;9(1):13-9
11829425
Br J Surg. 2000 Dec;87(12):1629-39
11122176
Am J Surg Pathol. 2005 Sep;29(9):1135-44
16096401
Int J Colorectal Dis. 2007 Aug;22(8):911-7
17318555
N Engl J Med. 1999 Mar 25;340(12):956-8
10089191
N Engl J Med. 1999 Mar 25;340(12):908-14
10089184
N Engl J Med. 2001 Sep 6;345(10):725-30
11547741
N Engl J Med. 1997 Oct 23;337(17):1188-94
9337377
Clin Cancer Res. 2008 May 1;14(9):2609-16
18451223
Cancer. 1993 Dec 1;72(11):3174-8
8242540
Nat Rev Cancer. 2002 Aug;2(8):563-72
12154349
Gastric Cancer. 1999 Nov;2(3):179-185
11957093
J Clin Oncol. 2003 Sep 15;21(18):3469-78
12972522
J Surg Oncol. 2006 Jan 1;93(1):13-8; discussion 18-9
16353185
Ann Surg Oncol. 2007 Oct;14(10):2861-6
17882497
Br J Surg. 1998 Jun;85(6):831-4
9667718
N Engl J Med. 2000 Feb 24;342(8):525-33
10684910
Cancer. 1999 Dec 15;86(12):2668-73
10594862
Ann Surg Oncol. 2009 Mar;16(3):609-13
19137375
World J Surg. 2003 May;27(5):558-61
12715223
N Engl J Med. 2007 Nov 1;357(18):1810-20
17978289
Gut. 1997 Apr;40(4):512-5
9176080
J Cancer Res Clin Oncol. 2004 Dec;130(12):733-40
15378353
Ann Surg. 2004 Jun;239(6):859-63; discussion 863-5
15166965
Cancer. 2001 Aug 15;92(4):753-60
11550144
Br J Surg. 2007 Jun;94(6):731-6
17377930
N Engl J Med. 1999 May 27;340(21):1687
10348686
Cancer Res. 1994 Jul 15;54(14):3853-6
8033106
Langenbecks Arch Surg. 2009 Jan;394(1):105-13
18626657
Cancer Res. 2000 Dec 15;60(24):6836-40
11156375
Cancer. 2005 Jan 15;103(2):358-67
15593354